Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

40.57
+2.075.38%
Post-market: 40.05-0.5200-1.28%16:50 EDT
Volume:1.44M
Turnover:57.73M
Market Cap:3.26B
PE:29.10
High:40.70
Open:39.67
Low:38.80
Close:38.50
52wk High:60.91
52wk Low:29.46
Shares:80.39M
Float Shares:78.97M
Volume Ratio:1.15
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.39
EPS(LYR):0.8200
ROE:8.77%
ROA:4.09%
PB:2.35
PE(LYR):49.48

Loading ...

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Tonix Pharma (TNXP) and Regeneron (REGN)

TIPRANKS
·
May 18

Veracyte TrueMRD test wins Medicare coverage for muscle-invasive bladder cancer monitoring

Reuters
·
May 15

Veracyte Secures Medicare Coverage for Truemrd Monitoring Test in Muscle-Invasive Bladder Cancer

THOMSON REUTERS
·
May 15

Veracyte Inc - Truemrd Monitoring Test Available for Order June 1, 2026

THOMSON REUTERS
·
May 15

Veracyte SVP, General Counsel Annie McGuire disposes 10,204 shares for $398,130.10

Reuters
·
May 09

Veracyte price target raised to $42 from $40 at Canaccord

TIPRANKS
·
May 07

Veracyte price target raised to $52 from $48 at UBS

TIPRANKS
·
May 07

Veracyte (VCYT) Margin Expansion And 166% Earnings Growth Test Premium Valuation Narratives

Simply Wall St.
·
May 07

Veracyte Is Maintained at Buy by UBS

Dow Jones
·
May 07

Stock Track | Veracyte Soars 17.77% Intraday on Strong Q1 Earnings Beat, Raised Guidance and Analyst Upgrades

Stock Track
·
May 06

UBS Adjusts Price Target on Veracyte to $52 From $48, Maintains Buy Rating

MT Newswires Live
·
May 06

Stock Track | Veracyte Soars 13.77% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track
·
May 06

Stock Track | Veracyte Soars 7.73% on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track
·
May 06

Veracyte Inc Earnings Call Signals Profitable Growth

TIPRANKS
·
May 06

Veracyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 06

Stock Track | Veracyte Soars 16.73% After-Hours on Strong Q1 Results and Raised Guidance

Stock Track
·
May 06

Veracyte Q1 FY26 net income rises 307% to $28.7 million; revenue climbs 21% to $139.1 million

Reuters
·
May 06

Veracyte Q1 Adj. EPS $0.52 Beats $0.15 Estimate, Sales $139.071M Beat $130.041M Estimate

Benzinga Earnings
·
May 06

BRIEF-Veracyte Q1 Revenue USD 139.1 Million Vs. IBES Estimate USD 130 Million

Reuters
·
May 06

Veracyte Outlook FY Revenue Growth 13-14%

THOMSON REUTERS
·
May 06